| Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy SO Kleeman, TM Thakir, B Demestichas, N Mourikis, D Loiero, M Ferrer, ... Cell Genomics 3 (8), 2023 | 5 | 2023 |
| ‘Secondary’acute lymphoblastic/lymphocytic leukemia-done playing second fiddle? YJRA Riazat-Kesh, J Mascarenhas, M Bar-Natan Blood Reviews 60, 101070, 2023 | 4 | 2023 |
| An overlooked mimic? Autoimmune myelofibrosis—A scoping review of the literature YJR Amel Riazat‐Kesh, A Maraveyas, L Martin, D Tremblay European Journal of Haematology 111 (5), 706-714, 2023 | 3 | 2023 |
| Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement D Sastow, J Tatarian, YJRA Riazat-Kesh, K Farina, M Becker, J Feld, ... Leukemia & Lymphoma 64 (12), 2002-2007, 2023 | 3 | 2023 |
| Central nervous system specific characteristics and outcomes in acute myeloid leukemia patients with neurologic involvement D Sastow, YJRA Riazat-Kesh, K Farina, J Feld, M Bar-Natan, A Keyzner, ... Blood 140 (Supplement 1), 11618-11620, 2022 | 1 | 2022 |
| Array CGH+ SNP in ALL Enhances Detection of Complex Cytogenetic Profiles and Suggests That PRSS1 Loss May Play a Role in Leukemogenesis H Levavi, D Ahire, YJRA Riazat-Kesh, T Sheng, DL Sastow, J Feld, ... Blood 142, 6062, 2023 | | 2023 |
| Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis D Tremblay, ZI Schwabkey, YJRA Riazat-Kesh, G Van Hyfte, NH Al Ali, ... Blood 142, 1830, 2023 | | 2023 |
| POSTER: ALL-625 Methotrexate Neurotoxicity in Adult Acute Lymphoblastic Leukemia H Levavi, A Khazak, YJRA Riazat-kesh, O Pail, M Kremyanskaya, ... Clinical Lymphoma Myeloma and Leukemia 23, S153, 2023 | | 2023 |
| ALL-625 Methotrexate Neurotoxicity in Adult Acute Lymphoblastic Leukemia H Levavi, A Khazak, YJRA Riazat-kesh, O Pail, M Kremyanskaya, ... Clinical Lymphoma Myeloma and Leukemia 23, S258, 2023 | | 2023 |
| AML-178 A Multi-institutional Analysis of Outcomes in Acute Myeloid Leukemia Patients With Central Nervous System Involvement D Sastow, J Tatarian, Y Riazat-Kesh, K Farina, J Feld, M Kremyanskaya, ... Clinical Lymphoma Myeloma and Leukemia 23, S275-S276, 2023 | | 2023 |
| POSTER: AML-178 A Multi-Institutional Analysis of Outcomes in Acute Myeloid Leukemia Patients With Central Nervous System Involvement D Sastow, J Tatarian, Y Riazat-Kesh, K Farina, J Feld, M Kremyanskaya, ... Clinical Lymphoma Myeloma and Leukemia 23, S157, 2023 | | 2023 |
| PB2231: AN OVERLOOKED MIMIC? AUTOIMMUNE MYELOFIBROSIS-A SCOPING REVIEW OF THE LITERATURE YJRA Riazat-Kesh, A Maraveyas, L Martin, D Tremblay HemaSphere 7 (S3), e1195994, 2023 | | 2023 |
| Pegaspargase is a viable option in elderly adults with acute lymphoblastic leukemia YJRA Riazat-Kesh, H Levavi, S Venugopal, C Beall, R Hoffman, ... Cancer Research 83 (7_Supplement), 5517-5517, 2023 | | 2023 |
| What factors affect allogeneic bone marrow transplant decisions in acute leukaemia patients? Does unconscious bias play a role? YJRA Riazat-Kesh, S Hibbs, F Oyesanya, M Smith BRITISH JOURNAL OF HAEMATOLOGY 193, 45-45, 2021 | | 2021 |
| UK Medical Council on Alcohol - National Essay Competition - Do the new UK Government guidelines for alcohol take gender equality too far? A Riazat-Kesh Annual Report of the UK Medical Council of Alcohol Legacy, 2017 | | 2017 |
